Fungi may be classified by the level of tissue affected as superficial, subcutaneous, and systemic. The term "opportunistic mycoses" is used to refer to serious fungal infections occurring in patients with compromised host defenses. The most common opportunistic mycoses include candidiasis, invasive aspergillosis, cryptococcal meningitis, and mucormycosis. During the past two decades, the incidence of these and other unusual opportunistic mycoses has been increasing, related to the use of broad-spectrum antibiotics, immusuppressive agents, anticancer and anti-AIDS drugs. Recently, Lass-Flörl et al. reported the in vitro antifungal properties of selective serotonin reuptake inhibitors (SSRIs) against Aspergillus species and Candida parapsilosis. Fluoxetine (1) and sertraline (2) showed the highest activity against these fungi with differences in susceptibility of the various isolates tested. Starting from this report and pursuing our personal interest on azole antifungal agents, we synthesized novel antimicotic derivatives as econazole (3) isomers (4), replacing the fluoxetine NHCH3 terminus with an imidazole ring.1 All new derivatives, evaluated for their antifungal activity against 20 strains of Candida albicans, showed a very potent anti-Candida activity, higher than miconazole and econazole. 1-(4-Chlorophenyl)-1-(2,4-dichlorophenoxy)-3-(1H-imidazol-1-yl)-propane was about 2-fold more active than econazole. High increase of activity was observed with methyl, nitro, fluorine and chlorine (Cl>F>CH3>NO2>CF3). References (1) Silvestri, R.; Artico, M.; La Regina, G.; Di Pasquali, A.; De Martino, G.; D’Auria, F. D.; Nencioni, L.; Palamara, A. T. Imidazole Analogues of fluoxetine, a novel class of anti-Candida agents. J. Med. Chem. 2004, 47, 3924-3926.

Imidazole derivatives highly active against Candida albicans / LA REGINA, Giuseppe; De Martino, G; D’Auria, F. D.; Nencioni, Lucia; Palamara, ANNA TERESA; Artico, Marino; Silvestri, Romano. - (2004). (Intervento presentato al convegno Cost D28 MC Action. Natural Products as a Source for Discovery, Synthesis, and Application of New Pharmaceuticals. tenutosi a Siena).

Imidazole derivatives highly active against Candida albicans

LA REGINA, GIUSEPPE
;
D’Auria F. D;NENCIONI, Lucia;PALAMARA, ANNA TERESA;ARTICO, Marino;SILVESTRI, Romano
2004

Abstract

Fungi may be classified by the level of tissue affected as superficial, subcutaneous, and systemic. The term "opportunistic mycoses" is used to refer to serious fungal infections occurring in patients with compromised host defenses. The most common opportunistic mycoses include candidiasis, invasive aspergillosis, cryptococcal meningitis, and mucormycosis. During the past two decades, the incidence of these and other unusual opportunistic mycoses has been increasing, related to the use of broad-spectrum antibiotics, immusuppressive agents, anticancer and anti-AIDS drugs. Recently, Lass-Flörl et al. reported the in vitro antifungal properties of selective serotonin reuptake inhibitors (SSRIs) against Aspergillus species and Candida parapsilosis. Fluoxetine (1) and sertraline (2) showed the highest activity against these fungi with differences in susceptibility of the various isolates tested. Starting from this report and pursuing our personal interest on azole antifungal agents, we synthesized novel antimicotic derivatives as econazole (3) isomers (4), replacing the fluoxetine NHCH3 terminus with an imidazole ring.1 All new derivatives, evaluated for their antifungal activity against 20 strains of Candida albicans, showed a very potent anti-Candida activity, higher than miconazole and econazole. 1-(4-Chlorophenyl)-1-(2,4-dichlorophenoxy)-3-(1H-imidazol-1-yl)-propane was about 2-fold more active than econazole. High increase of activity was observed with methyl, nitro, fluorine and chlorine (Cl>F>CH3>NO2>CF3). References (1) Silvestri, R.; Artico, M.; La Regina, G.; Di Pasquali, A.; De Martino, G.; D’Auria, F. D.; Nencioni, L.; Palamara, A. T. Imidazole Analogues of fluoxetine, a novel class of anti-Candida agents. J. Med. Chem. 2004, 47, 3924-3926.
2004
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/396702
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact